Receivables Financing Agreement Amendment No. 15

This Receivables Financing Agreement Amendment No. 15 (this “Amendment”), dated as of July 10, 2026, among DAVEY RECEIVABLES LLC, an Ohio limited liability company, as Borrower (together with its successors and assigns, the “Borrower”); THE DAVEY TREE EXPERT COMPANY, an Ohio corporation, in its individual capacity (“Davey Tree”) and as Servicer (in such capacity, together with its successors and assigns in such capacity, the “Servicer”); PNC BANK, NATIONAL ASSOCIATION, as LC Bank (in such capacity, together with its successors and assigns in such capacity, the “LC Bank”) and as a Lender, the other Lenders party hereto; and PNC BANK, NATIONAL ASSOCIATION (“PNC”), as Administrative Agent (in such capacity together with its successors and assigns in such capacity, the “Administrative Agent”).

WI TNE S S E TH:

…

CONSENT AND FIFTH AMENDMENT to loan and security agreement

CONSENT AND FIFTH AMENDMENT to loan and security AGREEMENT, dated as of July 9, 2026 (this "Consent and Amendment"), by and among Fidelity Private Credit Company LLC ("Existing Parent", "Existing Seller" and "Existing Portfolio Manager"), Fidelity Direct Lending Fund I JSPV LLC (the "Company"), the Lenders party hereto, State Street Bank and Trust Company, in its capacities as collateral agent ("Collateral Agent") and securities intermediary ("Securities Intermediary"), Virtus Group, LP, in its capacity as collateral administrator ("Collateral Administrator") and JPMorgan Chase Bank, National, as administrative agent (in such capacity, together with any successor administrative agent, the "Administrative Agent"). Capitalized terms used in this Consent and Amendment but not otherwise defined have the meanings given to them in the Credit Agreement (as defined below).

PRELIMINARY STATEMENTS:

…

THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATES IN THE UNITED STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM.

SECURED CONVERTIBLE PROMISSORY NOTE

** **

Date of Note: July 14, 2026

Principal Amount: $1,774,512.72

…

SETTLEMENT AND MUTUAL RELEASE AGREEMENT

This Settlement and Mutual Release Agreement ("Settlement Agreement") is entered into by and between **BION ENVIRONMENTAL TECHNOLOGIES, INC. **("BION"), **BION TECHNOLOGIES, INC. **("BION TECH"), **BION 3G-1 LLC **("3G-1"), (from time to time collectively referred to as "Bion Group"), and **THE HAMSTRA GROUP, INC. **("Hamstra"). The parties to this Settlement Agreement are referred to herein from time to time as the "Parties," or each singularly, as a "Party." The "Effective Date" is July 14, 2026.

Recitals

WHEREAS, Hamstra is a general contractor that was hired by BION to act as the general contractor to construct, amongst other things, an Ammonia Recovery System (the "Project") at the property located at 5093 East 700 North, Fair Oaks, Newton County, Indiana (the "Property").

WHEREAS, BION TECH and 3G-1 are subsidiaries and/or affiliates of BION.

…

CHANGE IN CONTROL AGREEMENT

This Change in Control Agreement (the “Agreement”) is made effective as of the 8th day of July 2026 (the “Effective Date”), by and between Home Federal Savings and Loan Association of Grand Island (the “Bank”), and Bradley M. Kool (the “Executive”).  Any reference to the “Company” shall mean Central Plains Bancshares, Inc., the proposed holding company of the Bank.  

RECITALS

WHEREAS, the Executive is currently employed as an executive officer of the Bank;

WHEREAS, the Bank desires to assure itself of the Executive’s continued active participation in the business of the Bank; and

WHEREAS, to induce the Executive to remain in the employ of the Bank and in consideration of the Executive’s agreeing to remain in the employ of the Bank, the parties desire to specify the severance benefits due to the Executive in the event his employment with the Bank terminates under specified circumstances.

…

AMENDMENT NO. 5 TO AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER AND REORGANIZATION

This AMENDMENT NO. 5 TO AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER AND REORGANIZATION, dated as of July 13, 2026 (this

“Amendment No. 5”), is entered into by and among flyExclusive, Inc., a Delaware corporation (“Parent”), FlyX Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), Jet.AI Inc., a Delaware corporation (the “Company”), and Jet.AI SpinCo, Inc., a Delaware corporation and, as of the date of this Amendment No. 5, wholly owned Subsidiary of the Company (“SpinCo”). Each of the foregoing parties is referred to herein as a “Party” and collectively as the “Parties”.

RECITALS

A.

Parent, Merger Sub, the Company and SpinCo entered into an Amended and Restated Agreement and Plan of Merger and Reorganization, dated as of May 6, 2025, as amended by that Amendment No. 1, dated July 30, 2025, that Amendment No. 2, dated October 10, 2025, that Amendment No. 3, dated January 13, 2026, and that Amendment No.

…

EXECUTIVE EMPLOYMENT AGREEMENT

** **

This **EXECUTIVE EMPLOYMENT AGREEMENT **(the “Agreement”) is made and entered into as of June 22, 2026, by and between SS INNOVATIONS INTERNATIONAL, INC., a Florida corporation, (the “Company”) and SARAH M. ROMANO, an individual “Executive”).

RECITALS

** **

WHEREAS, the Company desires to secure the services of Executive, and the Executive desires to furnish such services to the Company, on and subject to, the terms and conditions set forth in this Agreement; and

WHEREAS, Executive, due to the nature of Executive’s duties, will be provided access to the Company’s trade secrets and other confidential information and the Company desires to maintain the confidentiality of the same.

AGREEMENT

** **

NOW, THEREFORE, in consideration of the mutual covenants and agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:

…

AMENDMENT No. 3 TO THE CINGULATE INC. 2021 OMNIBUS

EQUITY INCENTIVE PLAN

** **

This third Amendment (the “Amendment”) to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan, as amended (the “Plan”) of Cingulate Inc. (the “Company”), is made as of May 18, 2026. All capitalized terms used but not defined in this Amendment shall have the meanings assigned to such terms in the Plan.

** **

W I T N E S S E T H:

** **

WHEREAS, Section 17.2 of the Plan reserves to the Board of Directors of the Company (the “Board”) the right to amend the Plan from time to time;

WHEREAS, the Board desires to increase the number of shares of Common Stock reserved for issuance under the Plan from 1,596,126 shares to 2,221,126 shares, subject to approval by the Company’s stockholders.

NOW, THEREFORE, be it effective as of the date of approval by the Company’s stockholders, the Plan is hereby amended as follows:

…

Exhibit 10.6

Final Form

CONTINGENT VALUE RIGHTS AGREEMENT

This **CONTINGENT VALUE RIGHTS AGREEMENT **(this “Agreement”), dated as of [●], is entered into by and between NextCure, Inc., a Delaware corporation (the “Company”), and [●], a [●], as the Rights Agent (as defined herein), and [●], a [●], solely in its capacity as the initial representative, agent and attorney in fact of the Holders (the “Representative”).

RECITALS

…

Exhibit 10.4

Final Form

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [•], 2026, is entered into by and among Avere Therapeutics, Inc., a Delaware corporation (the “Company”) and the several investors signatory hereto (individually as an “Investor” and collectively together with their respective permitted assigns, the “Investors”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement by and among the Company and the Investors party thereto, dated as of [•], 2026 (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).

WHEREAS:

…

Final Form

SECURITIES PURCHASE AGREEMENT

This SEC****URITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of [•], 2026, by and among Avere Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the Persons listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).

WHEREAS, the Company and the Investors are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the U.S. Securities Act of 1933, as amended (the “Securities Act”);

…

Exhibit 10.2

Final Form

PARENT SUPPORT AGREEMENT

This Support Agreement (this “Agreement”) is made and entered into as of July 14, 2026, by and among Avere Therapeutics, Inc., a Delaware corporation (the “Company”), NextCure, Inc., a Delaware corporation (“Parent”), and the undersigned stockholder of Parent (the “Stockholder” and each of the Stockholder, Company, and Parent, a “Party” and, collectively, the “Parties”). Capitalized terms used herein but not otherwise defined shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).

RECITALS

…